Lance E Davidson1, Ted D Adams2, Jaewhan Kim3, Jessica L Jones3, Mia Hashibe3, David Taylor3, Tapan Mehta4, Rodrick McKinlay5, Steven C Simper5, Sherman C Smith5, Steven C Hunt6. 1. Department of Exercise Sciences, Brigham Young University, Provo, Utah2Division of Cardiovascular Genetics, University of Utah, Salt Lake City. 2. Division of Cardiovascular Genetics, University of Utah, Salt Lake City3LiVe Well Center-Salt Lake Clinic, Intermountain Healthcare, Salt Lake City, Utah. 3. Division of Public Health, Department of Family and Preventive Medicine, University of Utah, Salt Lake City. 4. Nutrition Obesity Research Center, Department of Physical Therapy, University of Alabama at Birmingham. 5. Rocky Mountain Associated Physicians Inc, Salt Lake City, Utah. 6. Division of Cardiovascular Genetics, University of Utah, Salt Lake City7Department of Genetic Medicine, Weill Cornell Medicine in Qatar, Doha.
Abstract
IMPORTANCE: Bariatric surgery is effective in reducing all-cause and cause-specific long-term mortality. Whether the long-term mortality benefit of surgery applies to all ages at which surgery is performed is not known. OBJECTIVE: To examine whether gastric bypass surgery is equally effective in reducing mortality in groups undergoing surgery at different ages. DESIGN, SETTING, AND PARTICIPANTS: All-cause and cause-specific mortality rates and hazard ratios (HRs) were estimated from a retrospective cohort within 4 categories defined by age at surgery: younger than 35 years, 35 through 44 years, 45 through 54 years, and 55 through 74 years. Mean follow-up was 7.2 years. Patients undergoing gastric bypass surgery seen at a private surgical practice from January 1, 1984, through December 31, 2002, were studied. Data analysis was performed from June 12, 2013, to September 6, 2015. A cohort of 7925 patients undergoing gastric bypass surgery and 7925 group-matched, severely obese individuals who did not undergo surgery were identified through driver license records. Matching criteria included year of surgery to year of driver license application, sex, 5-year age groups, and 3 body mass index categories. INTERVENTION: Roux-en-Y gastric bypass surgery. MAIN OUTCOMES AND MEASURES: All-cause and cause-specific mortality compared between those undergoing and not undergoing gastric bypass surgery using HRs. RESULTS: Among the 7925 patients who underwent gastric bypass surgery, the mean (SD) age at surgery was 39.5 (10.5) years, and the mean (SD) presurgical body mass index was 45.3 (7.4). Compared with 7925 matched individuals not undergoing surgery, adjusted all-cause mortality after gastric bypass surgery was significantly lower for patients 35 through 44 years old (HR, 0.54; 95% CI, 0.38-0.77), 45 through 54 years old (HR, 0.43; 95% CI, 0.30-0.62), and 55 through 74 years old (HR, 0.50; 95% CI, 0.31-0.79; P < .003 for all) but was not lower for those younger than 35 years (HR, 1.22; 95% CI, 0.82-1.81; P = .34). The lack of mortality benefit in those undergoing gastric bypass surgery at ages younger than 35 years primarily derived from a significantly higher number of externally caused deaths (HR, 2.53; 95% CI, 1.27-5.07; P = .009), particularly among women (HR, 3.08; 95% CI, 1.4-6.7; P = .005). Patients undergoing gastric bypass surgery had a significantly lower age-related increase in mortality than severely obese individuals not undergoing surgery (P = .001). CONCLUSIONS AND RELEVANCE: Gastric bypass surgery was associated with improved long-term survival for all patients undergoing surgery at ages older than 35 years, with externally caused deaths only elevated in younger women. Gastric bypass surgery is protective against mortality even for older patients and also reduces the age-related increase in mortality observed in severely obese individuals not undergoing surgery.
IMPORTANCE: Bariatric surgery is effective in reducing all-cause and cause-specific long-term mortality. Whether the long-term mortality benefit of surgery applies to all ages at which surgery is performed is not known. OBJECTIVE: To examine whether gastric bypass surgery is equally effective in reducing mortality in groups undergoing surgery at different ages. DESIGN, SETTING, AND PARTICIPANTS: All-cause and cause-specific mortality rates and hazard ratios (HRs) were estimated from a retrospective cohort within 4 categories defined by age at surgery: younger than 35 years, 35 through 44 years, 45 through 54 years, and 55 through 74 years. Mean follow-up was 7.2 years. Patients undergoing gastric bypass surgery seen at a private surgical practice from January 1, 1984, through December 31, 2002, were studied. Data analysis was performed from June 12, 2013, to September 6, 2015. A cohort of 7925 patients undergoing gastric bypass surgery and 7925 group-matched, severely obese individuals who did not undergo surgery were identified through driver license records. Matching criteria included year of surgery to year of driver license application, sex, 5-year age groups, and 3 body mass index categories. INTERVENTION: Roux-en-Y gastric bypass surgery. MAIN OUTCOMES AND MEASURES: All-cause and cause-specific mortality compared between those undergoing and not undergoing gastric bypass surgery using HRs. RESULTS: Among the 7925 patients who underwent gastric bypass surgery, the mean (SD) age at surgery was 39.5 (10.5) years, and the mean (SD) presurgical body mass index was 45.3 (7.4). Compared with 7925 matched individuals not undergoing surgery, adjusted all-cause mortality after gastric bypass surgery was significantly lower for patients 35 through 44 years old (HR, 0.54; 95% CI, 0.38-0.77), 45 through 54 years old (HR, 0.43; 95% CI, 0.30-0.62), and 55 through 74 years old (HR, 0.50; 95% CI, 0.31-0.79; P < .003 for all) but was not lower for those younger than 35 years (HR, 1.22; 95% CI, 0.82-1.81; P = .34). The lack of mortality benefit in those undergoing gastric bypass surgery at ages younger than 35 years primarily derived from a significantly higher number of externally caused deaths (HR, 2.53; 95% CI, 1.27-5.07; P = .009), particularly among women (HR, 3.08; 95% CI, 1.4-6.7; P = .005). Patients undergoing gastric bypass surgery had a significantly lower age-related increase in mortality than severely obese individuals not undergoing surgery (P = .001). CONCLUSIONS AND RELEVANCE: Gastric bypass surgery was associated with improved long-term survival for all patients undergoing surgery at ages older than 35 years, with externally caused deaths only elevated in younger women. Gastric bypass surgery is protective against mortality even for older patients and also reduces the age-related increase in mortality observed in severely obese individuals not undergoing surgery.
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: David E Arterburn; Maren K Olsen; Valerie A Smith; Edward H Livingston; Lynn Van Scoyoc; William S Yancy; George Eid; Hollis Weidenbacher; Matthew L Maciejewski Journal: JAMA Date: 2015-01-06 Impact factor: 56.272
Authors: James E Mitchell; Faith Selzer; Melissa A Kalarchian; Michael J Devlin; Gladys W Strain; Katherine A Elder; Marsha D Marcus; Steve Wonderlich; Nicholas J Christian; Susan Z Yanovski Journal: Surg Obes Relat Dis Date: 2012-07-14 Impact factor: 4.734
Authors: Giovanni Castellini; Lucia Godini; Silvia Gorini Amedei; Valentina Galli; Giovanna Alpigiano; Elena Mugnaini; Marco Veltri; Alessandra H Rellini; Carlo Maria Rotella; Carlo Faravelli; Marcello Lucchese; Valdo Ricca Journal: Eat Weight Disord Date: 2013-09-08 Impact factor: 4.652
Authors: Matthew L Maciejewski; Edward H Livingston; Valerie A Smith; Andrew L Kavee; Leila C Kahwati; William G Henderson; David E Arterburn Journal: JAMA Date: 2011-06-12 Impact factor: 56.272
Authors: Ted D Adams; Lance E Davidson; Sheldon E Litwin; Ronette L Kolotkin; Michael J LaMonte; Robert C Pendleton; Michael B Strong; Russell Vinik; Nathan A Wanner; Paul N Hopkins; Richard E Gress; James M Walker; Tom V Cloward; R Tom Nuttall; Ahmad Hammoud; Jessica L J Greenwood; Ross D Crosby; Rodrick McKinlay; Steven C Simper; Sherman C Smith; Steven C Hunt Journal: JAMA Date: 2012-09-19 Impact factor: 56.272
Authors: Kari Johansson; Sven Cnattingius; Ingmar Näslund; Nathalie Roos; Ylva Trolle Lagerros; Fredrik Granath; Olof Stephansson; Martin Neovius Journal: N Engl J Med Date: 2015-02-26 Impact factor: 91.245
Authors: Per-Arne Svensson; Åsa Anveden; Stefano Romeo; Markku Peltonen; Sofie Ahlin; Maria Antonella Burza; Björn Carlsson; Peter Jacobson; Anna-Karin Lindroos; Hans Lönroth; Cristina Maglio; Ingmar Näslund; Kajsa Sjöholm; Hans Wedel; Bo Söderpalm; Lars Sjöström; Lena M S Carlsson Journal: Obesity (Silver Spring) Date: 2013-05-31 Impact factor: 5.002
Authors: Gretchen E White; Anita P Courcoulas; Wendy C King; David R Flum; Susan Z Yanovski; Alfons Pomp; Bruce M Wolfe; Konstantinos Spaniolas; Walter Pories; Steven H Belle Journal: Surg Obes Relat Dis Date: 2019-08-26 Impact factor: 4.734
Authors: Sarah B Cairo; Indrajit Majumdar; Aurora Pryor; Alan Posner; Carroll M Harmon; David H Rothstein Journal: Obes Surg Date: 2018-04 Impact factor: 4.129
Authors: Fernando Mendonça; Maria Manuel Silva; Daniela Salazar; Maria João Ferreira; Jorge Pedro; Vanessa Guerreiro; Sara Viana; Joao Sérgio Neves; Sandra Belo; Ana Varela; Paula Freitas; Davide Carvalho Journal: Obes Facts Date: 2020-12-15 Impact factor: 3.942
Authors: Michelle R Lent; Elizabeth Avakoff; Nicholas Hope; David S Festinger; Christopher D Still; Adam M Cook; Anthony T Petrick; Peter N Benotti; G Craig Wood Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: Ted D Adams; Lance E Davidson; Sheldon E Litwin; Jaewhan Kim; Ronette L Kolotkin; M Nazeem Nanjee; Jonathan M Gutierrez; Sara J Frogley; Anna R Ibele; Eliot A Brinton; Paul N Hopkins; Rodrick McKinlay; Steven C Simper; Steven C Hunt Journal: N Engl J Med Date: 2017-09-21 Impact factor: 91.245